# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Aug 1, 2025

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2025-08-01
- Accepted by EDGAR: Aug 1, 2025, 16:25 ET
- Period: 2025-08-01
- Accession: 0000950103-25-009701
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000095010325009701/dp232462_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000095010325009701/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000095010325009701/dp232462_8k.htm

Filed Aug 1, 2025.
Source: SEC EDGAR, the filing index for accession 0000950103-25-009701. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.